Rationale: Oral corticosteroids (OCS) are routinely used for the treatment of uncontrolled moderate-to-severe asthma despite significant adverse effects. We assessed the association between baseline characteristics and OCS reduction in patients with OCS-dependent severe asthma during VENTURE (NCT02528214).
No takes yet. Share an insight, caveat, or question.
Domingo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: